Accessibility Menu
Bausch + Lomb logo

Bausch + Lomb

(NYSE) BLCO

Current Price$14.91
Market Cap$5.30B
Since IPO (2022)-26%
5 YearN/A
1 Year+29%
1 Month-8%

Bausch + Lomb Financials at a Glance

Market Cap

$5.30B

Revenue (TTM)

$5.21B

Net Income (TTM)

-$219.00M

EPS (TTM)

-$0.62

P/E Ratio

-24.07

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$14.91

Volume

23,248.715

Open

$14.85

Previous Close

$14.87

Daily Range

$14.76 - $14.96

52-Week Range

$11.58 - $18.92

Estimated Earnings Date

Jul 29, 2026

BLCO: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bausch + Lomb

Industry

Healthcare Equipment and Supplies

Employees

13,000

CEO

Brenton L. Saunders, MBA

Headquarters

Vaughan, ON L4K 4B4, CA

BLCO Financials

Key Financial Metrics (TTM)

Gross Margin

56%

Operating Margin

6%

Net Income Margin

-4%

Return on Equity

-3%

Return on Capital

3%

Return on Assets

-2%

Earnings Yield

-4.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.30B

Shares Outstanding

356.54M

Volume

23.25K

Avg. Volume

457.80K

Financials (TTM)

Gross Profit

$2.79B

Operating Income

$188.00M

EBITDA

$535.00M

Operating Cash Flow

$283.00M

Capital Expenditure

-$349.00M

Free Cash Flow

-$66.00M

Cash & ST Invst.

$383.00M

Total Debt

$5.37B

Bausch + Lomb Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.24B

+9.4%

Gross Profit

$704.00M

+19.7%

Gross Margin

56.59%

N/A

Market Cap

$5.30B

N/A

Market Cap/Employee

$392.72K

N/A

Employees

13,500

N/A

Net Income

-$71.00M

+66.5%

EBITDA

$137.00M

+495.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$268.00M

+32.7%

Total Debt

$5.07B

+5.0%

Accounts Receivable

$1.11B

+9.8%

Inventory

$977.00M

-5.2%

Long Term Debt

$5.03B

+5.1%

Short Term Debt

$39.00M

-2.5%

Return on Assets

-1.59%

N/A

Return on Invested Capital

2.58%

N/A

Free Cash Flow

-$68.00M

+49.6%

Operating Cash Flow

$32.00M

+228.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRSPCRISPR Therapeutics AG
$55.39+2.40%
TFXTeleflex Incorporated
$122.25-3.74%
MMSIMerit Medical Systems, Inc.
$66.97-0.36%
PTCTPTC Therapeutics, Inc.
$81.12+2.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
NITON2off
$19.15+2.77%
KEELKeel Infrastructure
$7.12+0.13%
HIVEHive Digital Technologies
$5.16+0.21%
TQQQProShares Trust - ProShares UltraPro Qqq
$84.22+0.02%

Questions About BLCO

What is the current price of Bausch + Lomb?

Bausch + Lomb is trading at $14.85 per share.

What is the 52-week range for Bausch + Lomb?

Over the past 52 weeks, Bausch + Lomb has traded between $11.58 and $18.92.

How much debt does Bausch + Lomb have?

As of the most recent reporting period, Bausch + Lomb reported total debt of $5.07B.

How much cash does Bausch + Lomb have on hand?

Bausch + Lomb reported $279.00M in cash and cash equivalents in its most recent financial results.

What is Bausch + Lomb’s dividend yield?

Bausch + Lomb does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.